Katrien De Jaeger

Radboud University Nijmegen — Netherlands

Medicine · Health Sciences

26h-index5.0kcitations88works2.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(44), Advanced Radiotherapy Techniques(40), Lung Cancer Treatments and Mutations(20), Medical Imaging Techniques and Applications(19), Lung Cancer Research Studies(14)

Publications88 total

Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy
JAMA Network Open·2026· 1 citedOpen Access
Stage I non-small cell lung cancer: improving patient selection for minimally invasive lobectomy or stereotactic ablative radiotherapy based on clinical characteristics
British Journal of Cancer·2026
3083 Toxicity of concurrent biological cancer therapy and stereotactic radiotherapy: a comparison of retrospective and prospective data collection
Radiotherapy and Oncology·2025
Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trials
Lung Cancer·2024· 3 citedOpen Access
The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy – a nationwide cohort study
Lung Cancer·2024· 10 citedOpen Access
A taskforce for national improvement of innovation implementation in radiotherapy
Radiotherapy and Oncology·2024· 3 citedOpen Access
Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial
JNCI Journal of the National Cancer Institute·2023· 21 citedOpen Access
OC-0607 Pattern of brain metastases after HA-PCI and SRCF in SCLC: pooled findings of NCT01780675 and PREMER
Radiotherapy and Oncology·2023
The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation
Clinical Lung Cancer·2022· 8 citedOpen Access
Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70]
Lung Cancer·2021· 1 citedOpen Access
Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands
Lung Cancer·2021· 10 citedOpen Access
PO-1162 DLCA-R: Variation in elderly stage III NSCLC treated with definitive chemoradiation.
Radiotherapy and Oncology·2021
Reaction on the Interpretation of the Hippocampus Avoidance Prophylactic Cranial Irradiation Trial in SCLC (NCT01780675)
Journal of Thoracic Oncology·2021· 3 citedOpen Access
Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?
Journal of Thoracic Oncology·2021· 2 citedOpen Access
30P Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008–2018: A nationwide population-based study from the Netherlands
Journal of Thoracic Oncology·2021
Trends and variations in treatment of stage I–III non-small cell lung cancer from 2008 to 2018: A nationwide population-based study from the Netherlands
Lung Cancer·2021· 36 citedOpen Access
P21.03 Dutch Lung Cancer Audit-Radiotherapy: Real-World Data on Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy Only
Journal of Thoracic Oncology·2021· 1 citedOpen Access
P05.05 Real-World Data on Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)
Journal of Thoracic Oncology·2021· 1 citedOpen Access
Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)
Journal of Thoracic Oncology·2021· 140 citedOpen Access
Toxicity of stereotactic Radiotherapy in Combination with targeted System Therapies: prospective Analysis of the TOaSTT Database
Pure Amsterdam UMC·2021
page 1 of 5Next →

Frequent Co-authors

J. Belderbos(26), Joos V. Lebesque(20), Yvette Seppenwoolde(14), Liesbeth Boersma(13), Marcel van Herk(8), Paul Baas(7), Sara Müller(5), Edith Dieleman(5), Lambert Zijp(4), Wilma D. Heemsbergen(4), Yolande Lievens(4), Suresh Senan(3), Ben E.E.M. van den Borne(3), Ben J. Slotman(3), Egbert F. Smit(3), Johan Bussink(3), Gerben R. Borst(3), Martijn Engelsman(3), E. Damen(3), Ben J. Mijnheer(3)